| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.016 | 1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.012 | 1 |